Asthma and Allergy Foundation of America’s Post

Boehringer Ingelheim announced a $35 per month cap on out-of-pocket costs for their asthma and COPD inhalers. The price cap will apply to people with commercial/private insurance or no insurance*. Atrovent® HFA Combivent® Respimat® Spiriva® HandiHaler® Spiriva® Respimat® 25 mcg and 5 mcg Stiolto® Respimat® Striverdi® Respimat® What patients and providers need to know: https://lnkd.in/gggexjRw *Federal law prevents people on government insurance programs (Medicare/Medicaid/Tricare) from being eligible for this price cap program. #Asthma #COPD #RepiratoryHealth #HealthCare #AsthmaInhalers

  • Blue background with the text "New $35 Price Cap: AstraZeneca" and pictures of three inhalers and the text identifying them as "Atrovent HFA", "Combivent Respimat", and "Spiriva Respimat"
Thomas Martin III

Unlocking Evidence-Based Insights: Prioritizing Human Health and Building IEQ/IAQ Wellness

1mo

Factors that can harass employees and students in schools and workplaces, potentially wearing down their immune systems and causing health events over time, include: • Using non-certified paint on walls • Low-quality carpet • Cheap cabinets • Poor indoor air quality • Inadequate ventilation • High VOC emissions • Mold and moisture issues • Poor kitchen vapors Ensuring a healthy indoor environment in schools and workplaces is essential to maintaining well-being and productivity.

  • No alternative text description for this image
Like
Reply

To view or add a comment, sign in

Explore topics